RecruitingNot ApplicableNCT07250789

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)

Cognitive Screening of Individuals Diagnosed With Type 2 Diabetes and the Impact of a Multidomain Intervention Targeting Cognitive Decline (The Brain Care Study)


Sponsor

Steno Diabetes Center Copenhagen

Enrollment

420 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a combined brain-health program — including lifestyle changes, better diabetes management, and cognitive training — can reduce the risk of dementia in older adults with type 2 diabetes who show early signs of memory decline. It also screens for how common cognitive impairment is in this group. **You may be eligible if...** - You are 65 or older - You have type 2 diabetes - You are a patient at a participating clinic in Denmark - You speak and understand Danish - Screening study: You agree to cognitive testing - Intervention trial: In addition, your cognitive screening scores suggest some memory decline or elevated dementia risk **You may NOT be eligible if...** - You have already been diagnosed with dementia - You have a psychiatric, neurological, or other condition that prevents you from participating in cognitive testing - Your screening results suggest you already have dementia (you will be referred to your doctor instead) - You are unwilling to participate in parts of the multidomain brain health program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultidomain Intervention Targeting Cognitive Decline

The multidomain intervention will include the following: Optimization of pharmacological treatment/Pharmacological neuroprotection. Adjustment of HbA1c targets. Vascular risk factor management. Assessment of hearing impairment. Assessment of depression. Dialogue tools. Social interaction. Guidance on physical training. Cognitive training. Text message reminders.


Locations(3)

Department of Endocrinology, Rigshospitalet

Copenhagen, Denmark

Department of Endocrinology, Bispebjerg-Frederiksberg Hospital

Copenhagen, Denmark

Steno Diabetes Center Copenhagen

Herlev, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07250789


Related Trials